Login is required to access this page
  • File Size 50.71 MB
  • File Count 1
  • Create Date January 28, 2025
  • Last Updated January 28, 2025

Q4 2024 Terumo Corporation Valuation Analysis

Terumo Corporation is a global leader in medical technology, specializing in the development, manufacturing, and distribution of medical devices, pharmaceuticals, and healthcare products. Terumo has a strong presence in over 160 countries, with significant growth driven by increasing demand for minimally invasive surgeries and advanced medical solutions. Access the Terumo Corporation assessments today and make informed investment decisions with confidence!

Post a comment

We're a leading global provider of financial services with offices in Stockholm, London, New York and Singapore. The highest level of our financial services is guaranteed by professionalism, a deep understanding of the financial markets. MS Capital Consulting works with the world’s leading financial institutions, delivering the experience and helping them achieve high performance. Marius Ghisea is the President and CEO of MS Capital Consulting. He is an investment analyst and an advisor for institutional and individual investors. With 14 years experience in capital markets, Marius Ghisea provides advice for long-term investors with low-risk investments strategies.

Latest Portfolio

Need Any Help? Or Looking For an Agent

Working Hours : Sun-monday, 09am-5pm
© 2024 GrowthValuation.com. All Rights Reserved.